Collaborating for better health
Collaboration and coordination among various stakeholders – governments, international agencies, academia, and funding institutions – is crucial for the success of global health initiatives to build viral surveillance and action capabilities. Abbott understands this need and is committed to collaborating closely with its global partners to make healthcare more intuitive.
Abbott’s global network of research, academic, and public health collaborators are actively sequencing viruses to look for the next viral threat, including COVID-19 variants, through Abbott's Pandemic Defence Coalition, dedicated to the early detection of and rapid response to future pandemic threats.
The coalition makes it easier for all participating partners to share the latest information and samples and verify the tests within days rather than weeks or months. With continuous efforts to build defenses against the current pandemic and learn from it, Abbott aims to contribute to healthcare innovations that can prepare us for any future eventuality.
Disclaimer: This publication/article/editorial is meant for awareness/educational purposes and does not constitute or imply an endorsement, sponsorship or recommendation of any products. Please consult your doctor/healthcare practitioner before starting any diet, medication or exercise.
FOLLOW ABBOTT